Name: Xiang Guangya

Professor in School of Pharmacy

Phone: 86-27-83692793

Email: gyxiang1968@hotmail.com

Academic Areas: Department of Pharmceutical Science

Research Interest

Drug Delivery System, Nanotechnology, Drug Design and Synthesis

Education

Oversea Study and Visit

Visiting Scholar,Institue of Organic Chemstry,Tuebigen University,Germany,2001-11-06-2002-10-29

Visiting Scholar,School of Pharmacy, the Ohio State University,USA,2006-07-24-2007-08-04

Academic Memberships

Honours and Awards

Honours and Awards

[1] Guang Yang, Tan Yang, Wendian Zhang, Miao Lu,Xiang Ma,*, and Guangya Xiang*,In Vitro and in Vivo Antitumor Effects of Folate-Targeted Ursolic Acid Stealth Liposome,J. Agric. Food Chem.,2014,dx.doi.org/10.1021/jf405675g

[2] Chang Yang,Lun Ma,Xiaoju Zou,Guangya Xiang∗,Wei Chen∗,Surface plasmon-enhanced Ag/CuS nanocomposites for cancer treatment,Cancer Nano,2013,4:81-89

[3] Changqin Xiao, Minqiong Tang, Jian Li, Chen-ru Yin, Guangya Xiang∗, Li Xu∗,Determination of sildenafil, vardenafil and aildenafil in human plasma by dispersive liquid–liquid microextraction-back extraction based on ionic liquid and high performance liquid chromatography-ultraviolet detection,Journal of Chromatography B,2013,931:111-116

[4] Chang Yang, Lun Ma, Jason Maley, Ramaswami Sammynaiken,Renfei Feng, Guangya Xiang∗, and Wei Chen∗,Photoluminescence and X-Ray Excited Luminescence from Glutathione-Stabilized Gold Nanoparticles,Journal of Biomedical Nanotechnology,2013,9:1827–1836

[5] Chang Yang, Wei Chen, Brian Quang Bui, and Guangya Xiang∗,Recent Progress on the Liposomes Loaded with Quantum Dots,Rev. Nanosci. Nanotechnol,2012,1(4):1-14

[6] Jian Li, Yifei Huang, Lei Huang, Lei Ye, Zhou Zhou, Guangya Xiang∗, Li Xu∗,Determination of imatinib mesylate and compounds by field amplified sample stacking with large volume sample injection capillary electrophoresis,Journal of Pharmaceutical and Biomedical Analysis,2012,70:26-31

[7] Ye, L; Huang, YF; Li; Xiang, GY; Xu, L∗,Nonaqueous capillary electrophoresis of imatinib mesylate and related substances,JOURNAL OF SEPARATION SCIENCE ,2012,35(16):2108-2113

[8] Yao Lu, Nan Ding, Chang Yang, Lei Huang, Jian Liu, and Guangya Xiang∗,Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation,Journal of Liposome Research,2012,22(2):110-119

[9] Xianmei Shang*, Nan Ding, Guangya Xiang*,Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells,European Journal of Medicinal Chemistry,2012,48:305-312

[10] Nan Ding,Yao Lu, Robert J Lee, Chang Yang, Lei Huang, Jian Liu, Guangya Xiang∗,Folate receptor targeted fluorescentparamagnetic bimodal liposomes for tumor imaging,International Journal of Nanomedicine,2011,6:2513-2520

[11] Xiaolan Qu,Chang Yang,Jing Zhang,Nan Ding,Yao Lu,Lei Huang,Guangya Xiang∗,In-vitro evaluation of a folate-bovine serum albumin doxorubicin conjugate,Journal of Drug Targeting,2010,18(5):351-61

[12] Chang Yang, Nan Ding, Yibing Xu, Xiaolan Qu, Jing Zhang1, Chaoyang Zhao, Liang Hong, Yao Lu, Guangya Xiang*,,Folate receptor–targeted quantum dot liposomes as fluorescence probes,,Journal of Drug Targeting,2009,17(7):502-511

[13] Guangya Xiang*,Jun Wu,Yanhui Lu, Zhilan Liu,Robert J Lee,Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes,International Journal of Pharmaceuticals,2008,356:29-36

[14] Qi Zhang, Guang Ya Xiang* , Youjiu Zhang, et al.,Increase of Doxorubicin Sensitivity for Folate Receptor Positive Cells when given as the Prodrug N-(phenylacetyl) doxorubicin in Combination with Folate-conjugated PGA,Journal of Pharmaceutical Sciences,2006,95(10):2266-75.

[15] Bin Zhao, Xianmei Shang*, Ling Xu, Wendian Zhang, Guangya Xiang*,Novel mixed ligand di-n-butyltin(IV) complexes derived from,European Journal of Medicinal Chemistry,2014,76:87-97

[16] Zhi-Gang Cheng, Xu-Yong Dai, Li-Wei Li , Qiong Wan , Xiang Ma ,* ,Guangya Xiang*,Synthesis and Characterization of Impurities of Barnidipine,Molecules,2014,19, 1344-1352